Literature DB >> 12424196

The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot.

Yousef Mortazavi1, Bruno Merk, Jenny McIntosh, Judith C W Marsh, Hubert Schrezenmeier, Tim R Rutherford.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) may arise during long-term follow- up of aplastic anemia (AA), and many AA patients have minor glycosylphosphatidylinositol (GPI) anchor-deficient clones, even at presentation. PIG-A gene mutations in AA/PNH and hemolytic PNH are thought to be similar, but studies on AA/PNH have been limited to individual cases and a few small series. We have studied a large series of AA patients with a GPI anchor-deficient clone (AA/PNH), including patients with minor clones, to determine whether their pattern of PIG-A mutations was identical to the reported spectrum in hemolytic PNH. AA patients with GPI anchor-deficient clones were identified by flow cytometry and minor clones were enriched by immunomagnetic selection. A variety of methods was used to analyze PIG-A mutations, and 57 mutations were identified in 40 patients. The majority were similar to those commonly reported, but insertions in the range of 30 to 88 bp, due to tandem duplication of PIG-A sequences, and deletions of more than 10 bp were also seen. In 3 patients we identified identical 5-bp deletions by conventional methods. This prompted the design of mutation-specific polymerase chain reaction (PCR) primers, which were used to demonstrate the presence of the same mutation in an additional 12 patients, identifying this as a mutational hot spot in the PIG-A gene. Multiple PIG-A mutations have been reported in 10% to 20% of PNH patients. Our results suggest that the large majority of AA/PNH patients have multiple mutations. These data may suggest a process of hypermutation in the PIG-A gene in AA stem cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424196     DOI: 10.1182/blood-2002-07-2095

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Both PIGA and PIGL mutations cause GPI-a deficient isolates in the Tk6 cell line.

Authors:  Janice A Nicklas; Elizabeth W Carter; Richard J Albertini
Journal:  Environ Mol Mutagen       Date:  2015-05-13       Impact factor: 3.216

2.  Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test.

Authors:  B Höchsmann; R Leichtle; I von Zabern; S Kaiser; W A Flegel; H Schrezenmeier
Journal:  Vox Sang       Date:  2011-09-19       Impact factor: 2.144

3.  Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

Authors:  Tetsuichi Yoshizato; Bogdan Dumitriu; Kohei Hosokawa; Hideki Makishima; Kenichi Yoshida; Danielle Townsley; Aiko Sato-Otsubo; Yusuke Sato; Delong Liu; Hiromichi Suzuki; Colin O Wu; Yuichi Shiraishi; Michael J Clemente; Keisuke Kataoka; Yusuke Shiozawa; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Yasunobu Nagata; Takamasa Katagiri; Ayana Kon; Masashi Sanada; Phillip Scheinberg; Satoru Miyano; Jaroslaw P Maciejewski; Shinji Nakao; Neal S Young; Seishi Ogawa
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

Review 4.  Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.

Authors:  Tsutomu Shichishima; Hideyoshi Noji
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

Review 5.  Paroxysmal nocturnal hemoglobinuria in children.

Authors:  Marry M van den Heuvel-Eibrink
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Sensitivity of the Pig-a assay for detecting gene mutation in rats exposed acutely to strong clastogens.

Authors:  Javed A Bhalli; Joseph G Shaddock; Mason G Pearce; Vasily N Dobrovolsky
Journal:  Mutagenesis       Date:  2013-05-15       Impact factor: 3.000

Review 7.  Clonal hematopoiesis in acquired aplastic anemia.

Authors:  Seishi Ogawa
Journal:  Blood       Date:  2016-04-27       Impact factor: 22.113

8.  Neutral evolution in paroxysmal nocturnal hemoglobinuria.

Authors:  David Dingli; Lucio Luzzatto; Jorge M Pacheco
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

9.  Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.

Authors:  Yuzuru Kanakura; Kazuma Ohyashiki; Tsutomu Shichishima; Shinichiro Okamoto; Kiyoshi Ando; Haruhiko Ninomiya; Tatsuya Kawaguchi; Shinji Nakao; Hideki Nakakuma; Jun-ichi Nishimura; Taroh Kinoshita; Camille L Bedrosian; Keiya Ozawa; Mitsuhiro Omine
Journal:  Int J Hematol       Date:  2013-08-11       Impact factor: 2.490

10.  The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.

Authors:  Richard Kelly; Stephen Richards; Peter Hillmen; Anita Hill
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.